Scarica l'app Stockscreener
0.2884
0.80%
0.0023
Pre-mercato:
.29
0.0016
+0.55%
Panoramica
Notizia
Cronologia dei prezzi
Catena di opzioni
Financials
Perché BNGO Giù?
Forum
Previsione
Frazionamento azionario
Precedente Chiudi:
$0.2861
Aprire:
$0.36
Volume 24 ore:
38.30M
Relative Volume:
9.48
Capitalizzazione di mercato:
$29.41M
Reddito:
$36.12M
Utile/perdita netta:
$-232.49M
Rapporto P/E:
-0.018
EPS:
-16.0015
Flusso di cassa netto:
$-126.87M
1 W Prestazione:
+42.49%
1M Prestazione:
+12.83%
6M Prestazione:
-57.46%
1 anno Prestazione:
-84.74%
Intervallo 1D:
$0.25
$0.363
Intervallo di 1 settimana:
$0.20
$0.363
Portata 52W:
$0.194
$2.16
Bionano Genomics Inc Stock (BNGO) Company Profile
Nome
Bionano Genomics Inc
Settore
Industria
Telefono
(858) 888-7600
Indirizzo
9540 TOWNE CENTRE DRIVE, SAN DIEGO, CA
Confronta BNGO con altri titoli
| Azioni | Prezzo | Cap. di mercato | Reddito | Reddito netto | Flusso di cassa | EPS |
|---|---|---|---|---|---|---|
BNGO
Bionano Genomics Inc
|
0.2884 | 29.41M | 36.12M | -232.49M | -126.87M | -17.78 |
|
ISRG
Intuitive Surgical Inc
|
521.96 | 185.91B | 7.87B | 2.24B | 586.00M | 6.22 |
|
BDX
Becton Dickinson Co
|
226.87 | 65.59B | 20.18B | 1.71B | 3.07B | 5.94 |
|
ALC
Alcon Inc
|
84.89 | 41.99B | 9.76B | 1.16B | 665.00M | 2.34 |
|
RMD
Resmed Inc
|
228.69 | 33.57B | 4.81B | 1.11B | 1.35B | 7.55 |
|
WST
West Pharmaceutical Services Inc
|
327.56 | 23.72B | 2.88B | 499.60M | 321.60M | 6.74 |
Bionano Genomics Inc Stock (BNGO) Upgrades & Downgrades
| Data | Azione | Analista | Modifica della valutazione |
|---|---|---|---|
| 2024-11-15 | Downgrade | Ladenburg Thalmann | Buy → Neutral |
| 2024-09-10 | Downgrade | BTIG Research | Buy → Neutral |
| 2023-01-05 | Iniziato | Scotiabank | Sector Outperform |
| 2022-12-12 | Ripresa | BTIG Research | Buy |
| 2022-07-18 | Ripresa | Oppenheimer | Outperform |
| 2021-06-16 | Iniziato | BTIG Research | Buy |
| 2020-09-24 | Iniziato | Ladenburg Thalmann | Buy |
| 2020-04-08 | Iniziato | Oppenheimer | Outperform |
Mostra tutto
Bionano Genomics Inc Borsa (BNGO) Ultime notizie
S&P 500 Growth (IGX) QuotePress Release - The Globe and Mail
Nasdaq Biotechnology Index (NBI) QuotePress Release - The Globe and Mail
Bionano Announces Amendment to Senior Secured Convertible Debentures in Debt Restructuring that Improves Cash Runway - The Manila Times
Bionano Announces Amendment to Senior Secured Convertible Debentures in Debt Restructuring that Improves Cash Runway - GlobeNewswire Inc.
Senior Loan Invesco ETF (BKLN-A) QuotePress Release - The Globe and Mail
Bionano Announces Publication from Johns Hopkins School of Medicine Showing that OGM Outperformed Multiple Cytogenetic Assays in a Study of Bone and Soft Tissue Tumor Analysis - The Manila Times
Bionano's Groundbreaking Study: Optical Genome Mapping Achieves 100% Detection Rate in Cancer Analysis - StockTitan
Bionano Genomics stock hits 52-week low at $0.2 amid market challenges - Investing.com India
Bionano Announces the Publication of Stockholder Letter Regarding Support for Proxy Proposal - The Manila Times
Bionano Genomics Issues Critical Stockholder Letter Ahead of Special Meeting - StockTitan
Bionano Genomics, Inc. (NASDAQ:BNGO) Might Not Be As Mispriced As It Looks - Simply Wall St
Uber Technologies Inc (UBER-N) QuotePress Release - The Globe and Mail
Bionano Genomics announces presentations at ASH annual meeting - Nasdaq
Bionano Announces Presentations at the American Society of Hematology (ASH) Annual Meeting that Underscore OGM Utility Across Blood Cancer Research and Cell & Gene Therapy - The Manila Times
Bionano Genomics Showcases Breakthrough OGM Technology Across 13 Cancer Research Studies at ASH 2024 - StockTitan
Tractor Supply Company (TSCO-Q) QuotePress Release - The Globe and Mail
Bionano Genomics (STU:2Y30) Current Ratio : 1.43 (As of Sep. 2024) - GuruFocus.com
Bionano Genomics shareholders approve warrant share issuance By Investing.com - Investing.com Nigeria
Bionano Genomics shareholders approve warrant share issuance - Investing.com
Bionano Genomics (LTS:0A4K) Enterprise Value : $25.57 Mil (As of Dec. 01, 2024) - GuruFocus.com
Bionano Genomics (LTS:0A4K) Degree of Operating Leverage : 51.41 (As of Sep. 2024) - GuruFocus.com
Bionano Genomics (FRA:2Y30) Current Ratio : 1.43 (As of Sep. 2024) - GuruFocus.com
Bionano Genomics stock hits 52-week low at $0.2 By Investing.com - Investing.com Australia
Bionano Genomics stock hits 52-week low at $0.2 - Investing.com
BNGO (Bionano Genomics) Accumulated other comprehensive inc - GuruFocus.com
BNGO (Bionano Genomics) 50-Day SMA : $0.35 (As of Nov. 20, 2024) - GuruFocus.com
BNGO (Bionano Genomics) 6-Month Price Index : 0.20 (As of Nov. 20, 2024) - GuruFocus.com
Bionano Genomics (FRA:2Y30) Operating Margin % : -372.57% (As of Sep. 2024) - GuruFocus.com
BTIG maintains neutral on BNGO shares amid Q3 results and strategy shift - Investing.com
Bionano Genomics, Inc. (NASDAQ:BNGO) Q3 2024 Earnings Call Transcript - Insider Monkey
Bionano Genomics Inc (BNGO) Quarterly 10-Q Report - Quartzy
Bionano Genomics, Inc. Reports Earnings Results for the Third Quarter and Nine Months Ended September 30, 2024 - Marketscreener.com
Bionano Genomics stock hits 52-week low at $0.26 By Investing.com - Investing.com Australia
Bionano Reports Third Quarter 2024 Results and Highlights Recent Business Progress - The Manila Times
Bionano Genomics Inc (BNGO) Q3 2024 Earnings Call Highlights: St - GuruFocus.com
Bionano Genomics Inc (BNGO) Q3 2024 Earnings Call Highlights: Strategic Shifts Amid Revenue ... By GuruFocus - Investing.com Canada
Bionano Genomics Inc (BNGO) Q3 2024 Earnings Call Highlights: Strategic Shifts Amid Revenue ... - Yahoo Finance
Optical Genome Mapping Market Size, Share, Trends, - openPR
Bionano Genomics Sees Growth in OGM Adoption - TipRanks
Earnings call: Bionano reports Q3 revenue dip, shifts focus to efficiency - Investing.com Canada
Bionano Genomics (BNGO) Q3 2024 Earnings Call Transcript - MSN
Bionano Genomics Q3 Revenue Falls 35% Despite OGM System Growth; Reports Mixed Results | BNGO Stock News - StockTitan
Bionano Genomics stock hits 52-week low at $0.26 - Investing.com
Bionano to Report Third Quarter 2024 Financial Results and Host a Conference Call and Webcast on November 13, 2024 - Barchart
Earnings Outlook For Bionano Genomics - Benzinga
U.K. stocks higher at close of trade; Investing.com United Kingdom 100 up 0.67% - Investing.com
Asia stocks fall as China stimulus disappoints, deflation persists - Investing.com
XRP Climbs 10.07% In Bullish Trade - Investing.com UK
Bionano Genomics Inc (BNGO): Major Improvements, Worth A Look - Stocks Register
Bionano Genomics (BNGO) Sets Q3 2024 Earnings Call for November 13 | BNGO Stock News - StockTitan
Optical Genome Mapping Market to Witness 26.76% CAGR During - GlobeNewswire
Bionano Genomics Inc Azioni (BNGO) Dati Finanziari
Reddito
Reddito netto
Flusso di cassa
EPS
0.05%
1.85%
Apri su Yahoo
|
Apri su Google
|
Aperto in Finviz
|
Apri in MarketWatch
|
Aperto a EDGAR
|
Aperto su Reuters
Capitalizzazione:
|
Volume (24 ore):